Agren J, Thiemermann C, Foster SJ, Wang JE, Aasen AO. 2006.
Cytokine responses to CpG DNA in human leukocytes. Scand J
Immunol 64: 61–68.
Alberry M, Maddocks D, Jones M, et al. 2007. Free fetal DNA in
maternal plasma in anembryonic pregnancies: confirmation that the
origin is the trophoblast. Prenat Diagn 27: 415–418.
Babochkina T, Mergenthaler S, Dinges TM, Holzgreve W, Hahn S.
2005. Direct detection of fetal cells in maternal blood: a reappraisal
using a combination of two different Y chromosome-specific FISH
probes and a single X chromosome-specific probe. Arch Gynecol
Obstet 273: 166–169.
Bayrak-Toydemir P, Pergament E, Fiddler M. 2003. Applying a test
system for discriminating fetal from maternal cells. Prenat Diagn
23: 619–624.
Benachi A, Steffann GE, Ernault P, Olivi M, Dumez CJM. 2003.
Fetal DNA in maternal serum: does it persist after pregnancy? Hum
Genet 113: 76–79.
Bianchi DW. 2004. Circulating fetal DNA: its origin and diagnostic
potential-a review. Placenta 25(Suppl. A): S93–S101.
Bianchi DW, Hanson J. 2006. Sharpening the tools: a summary of
a National Institutes of Health workshop on new technologies
for detection of fetal cells in maternal blood for early prenatal
diagnosis. J Matern Fetal Neonatal Med 19: 199–207.
Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA.
1996. Male fetal progenitor cells perist in maternal blood for as long
as 27 years postpartum. Proc Natl Acad Sci U S A 93: 705–708.
Bianchi DW, Mahr A, Zickwolf GK, Houseal TW, Flint AF, Klinger
KW. 1992. Detection of fetal cells with 47,XY,+21 karyotype in
maternal peripheral blood. Hum Genet 90: 368–370.
Bianchi DW, Simpson JL, Jackson LG, et al. 2002. Fetal gender and
aneuploidy detection using fetal cells in maternal blood: analysis of
NIFTY I data. National Institute of Child Health and Development
Fetal Cell Isolation Study. Prenat Diagn 22: 609–615.
Birch L, English CA, O’Donoghue K, Barigye O, Fisk NM, Keer JT.
2005. Accurate and robust quantification of circulating fetal and
total DNA in maternal plasma from 5 to 41 weeks of gestation.
Clin Chem 51: 312–320.
Bischoff FZ, Marquez-Do DA, Martinez DI, et al. 2003. Intact fetal
cell isolation from maternal blood: improved isolation using
a simple whole blood progenitor cell enrichment approach
(RosetteSep). Clin Genet 63: 483–489.
Chan KC, Zhang J, Hui AB, et al. 2004. Size distributions of maternal
and fetal DNA in maternal plasma. Clin Chem 50: 88–92.
Chan KC, Ding C, Gerovassili A, et al. 2006. Hypermethylated
RASSF1A in maternal plasma: a universal fetal DNA marker that
improves the reliability of noninvasive prenatal diagnosis. Clin
Chem 52: 2211–2218.
Chim SS, Tong YK, Chiu RW, et al. 2005. Detection of the placental
epigenetic signature of the maspin gene in maternal plasma. Proc
Natl Acad Sci U S A 102: 14753–14758.
Chinnapapagari SK, Holzgreve W, Lapaire O, Zimmermann B, Hahn
S. 2005. Treatment of maternal blood samples with formaldehyde
does not alter the proportion of circulatory fetal nucleic acids (DNA
and mRNA) in maternal plasma. Clin Chem 51: 652–655.
Chiu RW, Lo YM. 2004. The biology and diagnostic applications of
fetal DNA and RNA in maternal plasma. Curr Top Dev Biol 61:
81–111.
Chiu RWK, Lui W, Cheung M, et al. 2006. Time profile of
appearance and disappearance of circulating placenta-derived
mRNA in maternal plasma. Clin Chem 52: 313–316.
Chiu RWK, Chim SSC, Wong IHN, et al. 2007. Hypermethylation
of RASSFIA in human and Rhesus placentas. Am J Pathol 170:
941–950.
Chung GT, Chiu RW, Chan KC, Lau TK, Leung TN, Lo YM. 2005.
Lack of dramatic enrichment of fetal DNA in maternal plasma by
formaldehyde treatment. Clin Chem 51: 655–658.
Clausen FB, Krog GR, Rieneck K, Dziegiel MH. 2007. Improvement
in fetal DNA extraction from maternal plasma. Evaluation of the
NucliSens Magnetic Extraction system and the QIAamp DSP Virus
Kit in comparison with the QIAamp DNA Blood Mini Kit. Prenat
Diagn 27: 6–10.
Cornelie S, Poulain-Godefroy O, Lund C, et al. 2004. Methylated
CpG-containing plasmid activates the immune system. Scand J
Immunol 59: 143–151.
Costa JM, Gautier E, Benachi A. 2004. Genetic analysis of the fetus
using maternal blood. Gynecol Obstet Fertil 32: 646–650.
Dhallan R, Au WC, Mattagajasingh S, et al. 2004. Methods to
increase the percentage of free fetal DNA recovered from the
maternal circulation. JAMA 291: 1114–1119.
Dhallan R, Guo X, Emche S, et al. 2007. A non-invasive test for
prenatal diagnosis based on fetal DNA present in maternal blood:
a preliminary study. Lancet 369: 474–481.
Fisher SJ, Cui TY, Zhang L, et al. 1989. Adhesive and degradative
properties of human placental cytotrophoblast cells in vitro. J Cell
Biol 109: 891–902.
Fraga MF, Ballestar E, Paz MF, et al. 2005. Epigenetic differences
arise during the lifetime of monozygotic twins. Proc Natl Acad Sci
U S A 102: 10604–10609.
Galbiati S, Smid M, Gambini D, et al. 2005. Fetal DNA detection in
maternal plasma throughout gestation. Hum Genet 117: 243–248.
Grunau C, Clark SJ, Rosenthal A. 2001. Bisulfite genomic sequencing:
systematic investigation of critical experimental parameters.
Nucleic Acids Res 29: E65–E65.
Guetta E, Gutstein-Abo L, Barkai G. 2005. Trophoblasts isolated
from the maternal circulation: in vitro expansion and potential
application in non-invasive prenatal diagnosis. J Histochem
Cytochem 53: 337–339.
Guetta E, Gordon D, Simchen MJ, Goldman B, Barkai G. 2003.
Hematopoietic progenitor cells as targets for non-invasive prenatal
diagnosis: detection of fetal CD34+ cells and assessment of postdelivery
persistence in the maternal circulation. Blood Cells Mol
Dis 30: 13–21.
Guldberg P, Worm J, Gronbaek K. 2002. Profiling DNA methylation
by melting analysis. Methods 27: 121–127.
Hahn S, Zhong X, Holzgreve W. 2007. Non-invasive prenatal
diagnosis of Down’s syndrome. Lancet 369: 1997–1998, author
reply 1998–9.
Herman JG. 2004. Circulating methylated DNA. Ann N Y Acad Sci
1022: 33–39.
Hobbs CA, Sherman SL, Yi P, et al. 2000. Polymorphisms in genes
involved in folate metabolism as maternal risk factors for Down
syndrome. Am J Hum Genet 67: 623–630.
Hult´en MA, Old RW. 2007. Non-invasive prenatal diagnosis of
Down’s syndrome. Lancet 369: 1997, author reply 1998–9.
Ingargiola I, Vaerman J-L, Debi`eve F, Palgen G, Verellen-Dumoulin
C, Hubinont C. 2003. Free fetal DNA concentration in maternal
plasma during normal labour at term. Prenat Diagn 23: 1077–1082.
Invernizzi P, Biondi ML, Battezzati PM, et al. 2002. Presence of fetal
DNA in maternal plasma decades after pregnancy. Hum Genet 110:
587–591.
Januchowski R, Prokop J, Jagodzinski PP. 2004. Role of epigenetic
DNA alterations in the pathogenesis of systemic lupus
erythematosus. J Appl Genet 45: 237–248.
Jahr S, Hentze H, Englisch S, et al. 2001. DNA fragments in the
blood plasma of cancer patients: quantitations and evidence for
their origin from apoptotic and necrotic cells. Cancer Res 61:
1659–1665.
Johnson-Hopson CN, Artlett CM. 2002. Evidence against the longterm
persistence of fetal DNA in maternal plasma after pregnancy.
Hum Genet 111: 575.
Lau TW, Leung TN, Chan LY, et al. 2002. Fetal DNA clearance
from maternal plasma is impaired in preeclampsia. Clin Chem 48:
2141–2146.
Legler TJ, Liu Z, Mavrou A, et al. 2007. Workshop report on the
extraction of foetal DNA from maternal plasma. Prenat Diagn 27:
824–829.
Li Y, Holzgreve W, Page-Christiaens GC, Gille JJ, Hahn S. 2004.
Improved prenatal detection of a fetal point mutation for
achondroplasia by the use of size-fractionated circulatory DNA in
maternal plasma–case report. Prenat Diagn 24: 896–898.
Li Y, Di Naro E, Vitucci A, Zimmermann B, Holzgreve W, Hahn S.
2005. Detection of paternally inherited fetal point mutations for
beta-thalassemia using size-fractionated cell-free DNA in maternal
plasma. JAMA 293: 843–849.
Librach CL, Werb Z, Fitzgerald ML, et al. 1991. 92-kD type IV
collagenase mediates invasion of human cytotrophoblasts. J Cell
Biol 113: 437–449.
Liu Q, Sommer SS. 2004. PAP: detection of ultra rare mutations
depends on P* oligonucleotides: “sleeping beauties” awakened by
the kiss of pyrophosphorolysis. Hum Mutat 23: 426–436.
Lo YM. 2006. Recent developments in fetal nucleic acids in maternal
plasma: implications to noninvasive prenatal fetal blood group
genotyping. Transfus Clin Biol 13: 50–52.
Lo YM, Chiu RW. 2007. Non-invasive prenatal diagnosis of Down’s
syndrome. Lancet 369: 1997, author reply 1998–1999.
Lo YM, Corbetta N, Chamberlain PF, et al. 1997. Presence of fetal
DNA in maternal plasma and serum. Lancet 350: 485–487.
Lo YM, Tein MS, Lau TK, et al. 1998. Quantitative analysis of fetal
DNA in maternal plasma and serum: implications for noninvasive
prenatal diagnosis. Am J Hum Genet 62: 768–775.
Lo YM, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm NM. 1999.
Rapid clearance of fetal DNA from maternal plasma. Am J Hum
Genet 64: 218–224.
Lo YMD, Lun FMF, Chan KCA, et al. 2007a. Digital PCR for the
molecular detection of fetal chromosomal aneuploidy. Proc Natl
Acad Sci U S A 104: 13116–13121.
Lo YM, Tsui NB, Chiu RW, et al. 2007b. Plasma placental RNA
allelic ratio permits noninvasive prenatal chromosomal aneuploidy
detection. Nat Med 13: 218–223.
Lui YY, Chik KW, Chiu RW, Ho CY, Lam CW, Lo YM. 2002.
Predominant hematopoietic origin of cell-free DNA in plasma and
serum after sex-mismatched bone marrow transplantation. Clin
Chem 48: 421–427.
Lun FM, Chiu RW, Leung TY, Leung TN, Lau TK, Lo YM. 2007.
Epigenetic analysis of RASSF1A gene in cell-free DNA in amniotic
fluid. Clin Chem 53: 796–798.
Maron JL, Johnson KL, Slonim D, et al. 2007. Gene expression
analysis in pregnant women and their infants identifies unique fetal
biomarkers that circulate in maternal blood. J Clin Invest 117:
3007–3019.
Martin GM. 2005. Epigenetic drift in aging identical twins. Proc Natl
Acad Sci U S A 102: 10413–10414.
Mavrou A, Kouvidi E, Antsaklis A, Souka A, Kitsiou Tzeli S,
Kolialexi A. 2007. Identification of nucleated red blood cells
in maternal circulation: a second step in screening for fetal
aneuploidies and pregnancy complications. Prenat Diagn 27:
150–153.
Nelson M, Eagle C, Langshaw M, Popp H, Kronenberg H. 2001.
Genotyping fetal DNA by non-invasive means: extraction from
maternal plasma. Vox Sang 80: 112–116.
Ng EK, Tsui NB, Lam NY, et al. 2002. Presence of filterable and
nonfilterable mRNA in the plasma of cancer patients and healthy
individuals. Clin Chem 48: 1212–1217.
Ng EK, Tsui NB, Lau TK, et al. 2003a. mRNA of placental origin is
readily detectable in maternal plasma. Proc Natl Acad Sci U S A
100: 4748–4753.
Ng EK, Leung TN, Tsui NB, et al. 2003b. The concentration of
circulating corticotropin-releasing hormone mRNA in maternal
plasma is increased in preeclampsia. Clin Chem 49: 727–731.
Old RW, Crea F, Puszyk W, Hulten MA. 2007. Candidate epigenetic
biomarkers for non-invasive prenatal diagnosis of Down syndrome.
Reprod Biomed Online 15: 227–235.
Oudejans CB, Go AT, Visser A, et al. 2003. Detection of chromosome
21-encoded mRNA of placental origin in maternal plasma. Clin
Chem 49: 1445–1449.
Partsalis T, Chan LY, Hurworth M, et al. 2006. Evidence of
circulating donor genetic material in bone allotransplantation. Int
J Mol Med 17: 1151–1155.
Poon LLM, Leung TN, Lau TK, Chow KCK, Lo YDM. 2002.
Differential DNA methylation between fetus and mother as a
strategy for detecting fetal DNA in maternal plasma. Clin Chem
48: 35–41.
Rijnders RJ, Christiaens GC, Soussan AA, van der Schoot CE. 2004.
Cell-free fetal DNA is not present in plasma of nonpregnant
mothers. Clin Chem 50: 697–681.
Saker A, Benachi A, Bonnefont JP, et al. 2006. Genetic characterisation
of circulating fetal cells allows non-invasive prenatal diagnosis
of cystic fibrosis. Prenat Diagn 26: 906–916.
Sekizawa A, Kondo T, Iwasaki M, et al. 2001. Accuracy of fetal
gender determination by analysis of DNA in maternal plasma. Clin
Chem 47: 1856–1858.
Smid M, Galbiati S, Vassollo A, et al. 2003. No evidence of fetal
DNA persistence in maternal plasma after pregnancy. Hum Genet
112: 617–618.
Smid M, Galbiati S, Lojacono A, et al. 2006. Correlation of fetal
DNA levels in maternal plasma with Doppler status in pathological
pregnancies. Prenat Diagn 26: 785–790.
Tjoa ML, Cindrova-Dvaies T, Spasic-Boskovic O, Bianchi DW,
Burton GJ. 2006. Trophoblastic oxidative stress and the release of
cell-free feto-placental DNA.
Tong YK, Lo YM. 2006. Plasma epigenetic markers for cancer
detection and prenatal diagnosis. Front Biosci 11: 2647–2656.
Tong YK, Ding C, Chiu RWK, et al. 2006. Noninvasive prenatal
detection of fetal trisomy 18 by epigenetic allelic ratio analysis
in maternal plasma: theoretical and empirical considerations. Clin
Chem 52: 2194–2202.
Tsui NB, Ng EK, Lo YM. 2002. Stability of endogenous and added
RNA in blood specimens, serum, and plasma. Clin Chem 48:
1647–1653.
Tsui NB, Chiu RW, Ding C, et al. 2005. Detection of trisomy 21
by quantitative mass spectrometric analysis of single-nucleotide
polymorphisms. Clin Chem 51: 2358–2362.
Van der Schoot CE, Soussan AA, Koelewijn J, Bonsel G, Paget-
Christiaens LG, de Haas M. 2006. Non-invasive antenatal RHD
typing. Transfus Clin Biol 13: 53–57.
Wakuda K, Yoshida Y. 1992. DNA ploidy and proliferative
characteristics of human trophoblasts. Acta Obstet Gynecol Scand
71: 12–16.
Weier JF, Weier HU, Jung CJ, et al. 2005. Human cytotrophoblasts
acquire aneuploidies as they differentiate to an invasive phenotype.
Dev Biol 279: 420–432.
Wilson IM, Davies JJ, Weber M, et al. 2006. Epigenomics: mapping
the methylome. Cell Cycle 5: 155–158.
Yamada Y, Watanabe H, Miura F, et al. 2004. A comprehensive
analysis of allelic methylation status of CpG islands on human
chromosome 21q. Genome Res 14: 247–266.
Yoshikawa T, Imazu S, Gao JQ, et al. 2006. Non-methylated CpG
motif packaged into fusogenic liposomes enhance antigen-specific
immunity in mice. Biol Pharm Bull 29: 105–109.
Zybina TG, Kaufmann P, Frank HG, Freed J, Kadyrov M, Biesterfeld
S. 2002. Genome multiplication of extravillous trophoblast
cells in human placenta in the course of differentiation and invasion
into endometrium and myometrium. I. Dynamics of polyploidization.
Tsitologiia 44: 1058–1067.